0,835  0,003  5 Hydroxytryptamine release stimulant
0,730  0,004  5 Hydroxytryptamine release inhibitor
0,719  0,004  Alpha adrenoreceptor antagonist
0,701  0,008  Antipsychotic
0,674  0,003  Dopamine D1 antagonist
0,654  0,003  Alpha 2 adrenoreceptor antagonist
0,658  0,012  Antidepressant
0,648  0,005  Antiadrenergic
0,650  0,013  Mood disorders treatment
0,639  0,005  Adrenaline antagonist
0,653  0,019  Analgesic
0,627  0,014  Antiparkinsonian
0,612  0,004  Alpha 1 adrenoreceptor antagonist
0,598  0,005  Muscle relaxant
0,593  0,004  Dopamine antagonist
0,591  0,017  Vasodilator, peripheral
0,577  0,004  Alpha 2a adrenoreceptor antagonist
0,587  0,032  Antineoplastic (lung cancer)
0,559  0,004  Alpha 1a adrenoreceptor antagonist
0,553  0,005  Sigma receptor agonist
0,555  0,010  Tumour necrosis factor alpha release inhibitor
0,550  0,005  Dopamine D2 antagonist
0,550  0,011  Cardiodepressant
0,546  0,007  Sedative
0,554  0,017  Spasmolytic
0,532  0,003  LDLR expression enhancer
0,536  0,010  Dependence treatment
0,494  0,004  Pneumotoxic
0,481  0,005  Skeletal muscle relaxant
0,494  0,037  Antineoplastic (colorectal cancer)
0,485  0,030  Respiratory analeptic
0,489  0,035  Antineoplastic (colon cancer)
0,480  0,028  CYP2D6 substrate
0,450  0,009  5 Hydroxytryptamine antagonist
0,446  0,008  Attention deficit/hyperactivity disorder treatment
0,443  0,005  5 Hydroxytryptamine 1A antagonist
0,465  0,031  Anxiolytic
0,432  0,005  Dopamine agonist
0,434  0,008  5 Hydroxytryptamine 2 antagonist
0,418  0,001  Factor III inhibitor
0,442  0,025  CYP2D6 inhibitor
0,438  0,025  Cardiovascular analeptic
0,418  0,009  Cholinergic
0,424  0,019  Psychostimulant
0,447  0,042  Prostate cancer treatment
0,435  0,036  CYP2C19 substrate
0,448  0,049  Antipruritic, allergic
0,403  0,006  Cocaine dependence treatment
0,403  0,006  5 Hydroxytryptamine 1 antagonist
0,470  0,073  Caspase 9 stimulant
0,403  0,011  Antimigraine
0,397  0,007  Bipolar disorder treatment
0,456  0,066  Alzheimer's disease treatment
0,396  0,007  5 Hydroxytryptamine 2A antagonist
0,451  0,066  Antineoplastic (breast cancer)
0,385  0,004  Dopamine D5 antagonist
0,437  0,056  Histamine release inhibitor
0,427  0,049  Cognition disorders treatment
0,381  0,005  Alpha 1b adrenoreceptor antagonist
0,394  0,021  Antineoplastic enhancer
0,381  0,009  5 Hydroxytryptamine 2B antagonist
0,375  0,005  Alpha 2b adrenoreceptor antagonist
0,388  0,032  Antineurogenic pain
0,354  0,004  Alpha 1 adrenoreceptor agonist
0,354  0,005  Alpha 2c adrenoreceptor antagonist
0,387  0,040  Vasodilator, coronary
0,354  0,009  5 Hydroxytryptamine 1E antagonist
0,387  0,049  Aldehyde oxidase inhibitor
0,337  0,004  Alpha adrenoreceptor agonist
0,346  0,020  Sleep disorders treatment
0,371  0,045  Analeptic
0,389  0,066  Transcription factor NF kappa B inhibitor
0,329  0,010  DNA intercalator
0,359  0,044  Calcium channel activator
0,420  0,104  Apoptosis agonist
0,382  0,067  CYP3A4 substrate
0,353  0,044  Hypoxia-inducible factor 1 alpha inhibitor
0,309  0,005  Alpha 1d adrenoreceptor antagonist
0,326  0,023  Tyrosine 3 hydroxylase inhibitor
0,317  0,019  Antialcoholic
0,327  0,030  Antiarrhythmic
0,343  0,048  UGT1A9 substrate
0,316  0,022  Male reproductive disfunction treatment
0,339  0,046  Huntington's disease treatment
0,305  0,013  Acetylcholinesterase inhibitor
0,348  0,058  Antineoplastic (ovarian cancer)
0,310  0,020  Antineoplastic (squamous cell carcinoma)
0,332  0,044  Cardiotonic
0,394  0,109  Antineoplastic (solid tumors)
0,346  0,066  Antithrombotic
0,296  0,019  Tumour necrosis factor antagonist
0,361  0,085  CYP2C19 inhibitor
0,281  0,005  Opioid kappa receptor antagonist
0,294  0,020  Tubulin antagonist
0,318  0,044  Antineoplastic (liver cancer)
0,350  0,083  Ulceration
0,274  0,007  Dopamine D3 antagonist
0,326  0,060  Cardioprotectant
0,327  0,067  Caspase 3 stimulant
0,268  0,010  5 Hydroxytryptamine agonist
0,272  0,014  Topoisomerase I inhibitor
0,264  0,007  5 Hydroxytryptamine 1A agonist
0,263  0,007  5 Hydroxytryptamine 7 antagonist
0,268  0,013  Butyrylcholinesterase inhibitor
0,308  0,055  Antineoplastic (cervical cancer)
0,251  0,005  Antineoplastic alkaloid
0,278  0,032  UGT2B7 substrate
0,345  0,101  Analgesic, non-opioid
0,298  0,056  Radiosensitizer
0,286  0,047  Antimitotic
0,276  0,040  Anesthetic general
0,288  0,052  Vasodilator
0,245  0,010  Antischistosomal
0,242  0,007  Sigma receptor antagonist
0,253  0,019  Toxic, respiratory center
0,286  0,054  Acute neurologic disorders treatment
0,298  0,069  CYP1A2 substrate
0,293  0,065  UGT2B4 substrate
0,319  0,094  Antileukemic
0,262  0,038  P-glycoprotein inhibitor
0,241  0,017  VEGF expression inhibitor
0,238  0,017  Antitussive
0,251  0,030  UGT1A3 substrate
0,225  0,005  Dopamine D2 agonist
0,237  0,021  Neuropathy treatment
0,275  0,060  5 Hydroxytryptamine uptake stimulant
0,225  0,011  Acetylcholine nicotinic antagonist
0,242  0,029  Protein kinase stimulant
0,268  0,056  Antineoplastic (sarcoma)
0,221  0,015  5 Hydroxytryptamine 2C antagonist
0,228  0,023  Uterine stimulant
0,226  0,022  Toll-Like receptor antagonist
0,321  0,117  MAP kinase kinase 6 inhibitor
0,230  0,030  Erectile dysfunction treatment
0,200  0,004  Alpha 2 adrenoreceptor agonist
0,203  0,008  Prolactin inhibitor
0,244  0,049  UGT1A1 substrate
0,249  0,055  Antiparkinsonian, rigidity relieving
0,214  0,021  Autism spectrum disorders treatment
0,224  0,033  Acetylcholine M1 receptor antagonist
0,298  0,107  Stroke treatment
0,209  0,019  Antismoking
0,216  0,026  UGT2B10 substrate
0,262  0,072  Antineoplastic (non-small cell lung cancer)
0,207  0,018  Nav1.1 sodium channel blocker
0,193  0,005  Potassium channel (Ca-activated) blocker
0,202  0,014  Opioid antagonist
0,190  0,004  Potassium channel small-conductance Ca-activated blocker
0,185  0,004  Sigma 2 receptor antagonist
0,242  0,061  Antihypotensive
0,291  0,113  CYP2C9 substrate
0,213  0,041  Antipruritic
0,181  0,011  Analgesic, opioid
0,191  0,022  Expectorant
0,212  0,045  Antineoplastic (gastric cancer)
0,207  0,040  Antiparkinsonian, tremor relieving
0,244  0,078  Superoxide dismutase inhibitor
0,168  0,005  Tourette's syndrome treatment
0,251  0,093  Antineoplastic (melanoma)
0,232  0,075  Potassium channel blocker
0,292  0,136  TNF expression inhibitor
0,190  0,035  Cholinergic antagonist
0,166  0,011  Neuronal nicotinic receptor antagonist
0,236  0,081  Antineoplastic (glioma)
0,188  0,034  Acetylcholine antagonist
0,182  0,029  Movement disorders treatment
0,165  0,014  5 Hydroxytryptamine uptake inhibitor
0,160  0,009  Dopamine uptake inhibitor
0,255  0,106  Hepatic disorders treatment
0,160  0,011  Tocolytic
0,194  0,046  Antineoplastic (carcinoma)
0,163  0,016  Dopamine D4 antagonist
0,168  0,023  Constipation treatment
0,234  0,090  DNA damaging
0,149  0,006  Narcotic antagonist
0,156  0,015  5 Hydroxytryptamine 1F antagonist
0,186  0,047  UGT2B9 substrate
0,182  0,044  Toll-Like receptor 9 antagonist
0,171  0,035  Nav1.6 sodium channel blocker
0,157  0,021  Breast cancer-resistant protein inhibitor
0,152  0,017  Opioid mu receptor antagonist
0,269  0,134  Antineoplastic (non-Hodgkin's lymphoma)
0,149  0,014  5 Hydroxytryptamine 1 agonist
0,239  0,104  Antineoplastic (multiple myeloma)
0,167  0,035  Cyclooxygenase 3 inhibitor
0,137  0,007  Opioid kappa receptor agonist
0,251  0,121  Antiallergic
0,152  0,022  Phosphodiesterase IV inhibitor
0,247  0,118  CYP3A4 inhibitor
0,214  0,087  Free radical scavenger
0,130  0,005  Complement C5a chemotactic receptor antagonist
0,211  0,086  Cyclic AMP phosphodiesterase inhibitor
0,146  0,022  Acetylcholine M3 receptor agonist
0,146  0,024  Calcium antagonist
0,128  0,006  5 Hydroxytryptamine 2 agonist
0,153  0,031  Antihistaminic
0,176  0,056  Diuretic
0,173  0,055  UGT2B15 substrate
0,166  0,049  Phosphodiesterase inhibitor
0,216  0,099  Hypoglycemic
0,164  0,048  Sodium channel blocker
0,130  0,013  Nicotinic alpha4beta2 receptor antagonist
0,131  0,016  Phosphodiesterase XI inhibitor
0,131  0,016  Phosphodiesterase 11A inhibitor
0,148  0,032  Bronchodilator
0,117  0,005  5 Hydroxytryptamine 7 agonist
0,144  0,032  UGT2B1 substrate
0,137  0,026  Acetylcholine release stimulant
0,126  0,016  Beta tubulin antagonist
0,213  0,104  DNA synthesis inhibitor
0,173  0,064  Prostate disorders treatment
0,176  0,067  Prostatic (benign) hyperplasia treatment
0,206  0,097  NOS2 expression inhibitor
0,141  0,032  Histamine antagonist
0,159  0,052  Antifungal enhancer
0,115  0,011  Opioid agonist
0,196  0,093  HERG channel blocker
0,119  0,018  mTOR complex 2 inhibitor
0,253  0,154  Antiobesity
0,160  0,062  Lipid peroxidase inhibitor
0,119  0,021  Antiprotozoal activity enhancer
0,102  0,004  Prolactin release inhibitor
0,141  0,044  Antineoplastic (uterine cancer)
0,101  0,004  Vesicle monoamine transporter inhibitor
0,101  0,004  Alpha 1L adrenoreceptor antagonist
0,160  0,064  Antiischemic, cerebral
0,194  0,099  UGT1A6 substrate
0,144  0,051  TRKB antagonist
0,104  0,011  Nicotinic receptor alpha7 subunit antagonist
0,118  0,026  Opioid delta receptor antagonist
0,227  0,136  GST M1-1 substrate
0,141  0,050  Acetylcholine muscarinic antagonist
0,094  0,003  Dopamine D1 agonist
0,104  0,013  5 Hydroxytryptamine 2A agonist
0,158  0,068  Interferon gamma antagonist
0,119  0,030  mTOR complex 1 inhibitor
0,147  0,059  Psychosexual dysfunction treatment
0,183  0,095  Antineoplastic (glioblastoma multiforme)
0,138  0,051  Antiprotozoal (Amoeba)
0,204  0,117  Interleukin agonist
0,103  0,018  Adrenaline uptake inhibitor
0,104  0,019  Glycine receptor agonist
0,117  0,033  Histamine H1 receptor antagonist
0,109  0,025  Glycine receptor antagonist
0,225  0,144  Antihypertensive
0,154  0,074  Antimutagenic
0,173  0,094  CYP2B6 inhibitor
0,196  0,117  Antioxidant
0,121  0,043  Toll-Like receptor 4 antagonist
0,148  0,070  Hemostatic
0,094  0,016  Uterine relaxant
0,215  0,138  Metabolic disease treatment
0,139  0,063  Sodium channel (voltage-gated) blocker
0,078  0,003  Guanylate cyclase inhibitor
0,109  0,034  Restless leg syndrome treatment
0,097  0,022  Prokinetic
0,098  0,024  Cushing's syndrome treatment
0,149  0,075  Raynaud's phenomenon treatment
0,183  0,109  Potassium channel (Voltage-sensitive) blocker
0,106  0,033  Acetylcholine nicotinic agonist
0,138  0,065  Nav1.2 sodium channel blocker
0,175  0,103  Antihypertriglyceridemic
0,118  0,046  Antiemetic
0,089  0,019  5 Hydroxytryptamine 5A antagonist
0,112  0,042  UGT2B11 substrate
0,085  0,015  Dopamine transporter inhibitor
0,157  0,089  Nitric oxide antagonist
0,112  0,044  Phosphodiesterase 7B inhibitor
0,198  0,130  Antineoplastic (pancreatic cancer)
0,093  0,025  Acetylcholine M5 receptor agonist
0,073  0,006  Melatonin agonist
0,097  0,030  Acetylcholine M4 receptor antagonist
0,224  0,157  Sodium/bile acid cotransporter inhibitor
0,213  0,146  FMO3 substrate
0,133  0,066  Alpha-N-acetylglucosaminidase inhibitor
0,086  0,020  5 Hydroxytryptamine 6 antagonist
0,151  0,086  UGT1A4 substrate
0,082  0,017  Opioid mu receptor agonist
0,071  0,008  Nociceptin (N/OFQ) receptor antagonist
0,071  0,008  Sigma 1 receptor antagonist
0,179  0,116  VCAM1 expression inhibitor
0,082  0,020  5 Hydroxytryptamine 5 antagonist
0,082  0,020  Phosphodiesterase 4C inhibitor
0,178  0,116  Antiamyloidogenic
0,068  0,006  5 Hydroxytryptamine 2B agonist
0,080  0,020  Alpha tubulin antagonist
0,064  0,004  Nicotinic alpha3beta4 receptor agonist
0,169  0,111  Teratogen
0,128  0,071  Antihelmintic (Trematoda)
0,080  0,023  Beta 3 adrenoreceptor antagonist
0,096  0,039  Phosphodiesterase 4D inhibitor
0,115  0,059  Myasthenia Gravis treatment
0,066  0,009  Dopamine D5 agonist
0,163  0,107  Abortion inducer
0,081  0,025  NMDA 2C receptor antagonist
0,061  0,005  Nociceptin (N/OFQ) receptor agonist
0,217  0,161  Interleukin 2 agonist
0,119  0,064  Menstruation disorders treatment
0,154  0,098  TRKC antagonist
0,115  0,060  5 Hydroxytryptamine 3A agonist
0,112  0,058  Electron transport complex I inhibitor
0,090  0,036  CC chemokine 5 receptor agonist
0,145  0,091  Carcinogenic, group 1
0,086  0,032  Phosphodiesterase 4B inhibitor
0,078  0,025  Acetylcholine M5 receptor antagonist
0,072  0,020  Glycine transporter inhibitor
0,099  0,046  Phosphodiesterase I inhibitor
0,127  0,075  NADPH oxidase inhibitor
0,074  0,023  NMDA 2B receptor antagonist
0,067  0,016  5 Hydroxytryptamine 2C agonist
0,126  0,075  Vanilloid 1 agonist
0,089  0,038  NMDA 2 receptor antagonist
0,191  0,144  Chemoprotective
0,103  0,056  Obsessive-compulsive disorder treatment
0,093  0,046  Granulocyte macrophage colony stimulating factor agonist
0,131  0,084  Activin receptor-like kinase 2 inhibitor
0,055  0,009  Melatonin 2 agonist
0,076  0,031  Beta adrenoreceptor antagonist
0,075  0,030  Phosphodiesterase VII inhibitor
0,113  0,069  Microtubule formation inhibitor
0,090  0,048  Sodium/hydrogen exchanger 5 inhibitor
0,093  0,052  Acetylcholine agonist
0,060  0,019  Phosphodiesterase 3B inhibitor
0,172  0,131  Cytostatic
0,069  0,029  Calcium channel P-type blocker
0,100  0,061  Glutamate (mGluR7) agonist
0,136  0,097  Antinephritic
0,152  0,113  Non-steroidal antiinflammatory agent
0,074  0,035  5 Hydroxytryptamine 1D antagonist
0,059  0,022  Histamine H3 receptor antagonist
0,075  0,039  Phosphodiesterase III inhibitor
0,106  0,070  Polo-like kinase-4 inhibitor
0,062  0,027  Acetylcholine M2 receptor agonist
0,038  0,004  NMDA receptor phencyclidine site antagonist
0,085  0,051  Adrenaline agonist
0,066  0,031  Nicotinic neuronal receptor agonist
0,049  0,015  Phenylethanolamine N methyltransferase inhibitor
0,114  0,080  Nav1.3 sodium channel blocker
0,073  0,039  5 Hydroxytryptamine 1B antagonist
0,163  0,130  Antiprotozoal (Leishmania)
0,123  0,091  Neurotrophic factor
0,223  0,191  Antineoplastic (small cell lung cancer)
0,061  0,029  Melanin-concentrating hormone receptor 1 antagonist
0,057  0,027  5 Hydroxytryptamine 4 antagonist
0,159  0,128  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,040  0,010  Melatonin antagonist
0,032  0,003  Melatonin 2 antagonist
0,067  0,038  Acetylcholine M2 receptor antagonist
0,113  0,084  Antifungal (Pneumocystis)
0,156  0,129  Neurotrophic factor enhancer
0,086  0,059  Insulin growth factor antagonist
0,174  0,148  Radioprotector
0,168  0,142  5 Hydroxytryptamine 3E antagonist
0,061  0,035  VEGFR2 expression inhibitor
0,044  0,019  Glycine transporter 1 inhibitor
0,029  0,004  Melatonin receptor 1A antagonist
0,111  0,088  Toll-Like receptor 2 antagonist
0,082  0,059  Insulin like growth factor 1 antagonist
0,132  0,110  Ca2+-transporting ATPase inhibitor
0,128  0,107  Adenylate cyclase stimulant
0,207  0,187  FMO1 substrate
0,068  0,048  Toll-Like receptor 7 antagonist
0,130  0,110  Pulmonary hypertension treatment
0,047  0,027  Nicotinic receptor alpha3 subunit antagonist
0,040  0,020  5 Hydroxytryptamine 3B antagonist
0,082  0,063  NMDA receptor antagonist
0,026  0,008  Melatonin 1 antagonist
0,054  0,035  Nicotinic alpha3beta2 receptor antagonist
0,027  0,009  Vesicular acetylcholine transporter inhibitor
0,089  0,072  Alpha 2d adrenoreceptor antagonist
0,058  0,043  Ryanodine receptor antagonist
0,031  0,015  5 Hydroxytryptamine 6 agonist
0,059  0,044  Potassium channel intermediate-conductance Ca-activated blocker
0,060  0,045  Narcolepsy treatment
0,076  0,062  Phosphodiesterase 3A inhibitor
0,049  0,035  Nicotinic receptor alpha4 subunit antagonist
0,145  0,131  Phobic disorders treatment
0,058  0,045  Phosphodiesterase 1A inhibitor
0,173  0,160  Proliferative diseases treatment
0,097  0,084  Multidrug resistance-associated protein 1 inhibitor
0,180  0,167  Flavin-containing monooxygenase substrate
0,073  0,061  Estrogen receptor alpha antagonist
0,054  0,043  5 Hydroxytryptamine 3 antagonist
0,137  0,127  Septic shock treatment
0,125  0,116  GABA C receptor rho-2 antagonist
0,088  0,080  Insulin receptor antagonist
0,023  0,014  Follicle-stimulating hormone agonist
0,098  0,090  Alkylator
0,077  0,070  Histamine N-methyltransferase inhibitor
0,065  0,058  Phosphodiesterase V inhibitor
0,046  0,039  Topoisomerase II beta inhibitor
0,089  0,082  Mediator release inhibitor
0,202  0,196  Immunosuppressant
0,103  0,098  Anesthetic
0,106  0,102  Antiviral (Influenza B)
0,164  0,160  Age-related macular degeneration treatment
0,044  0,040  Phosphodiesterase 4A inhibitor
0,028  0,024  Acetylcholine M4 receptor agonist
0,124  0,121  Arachidonic acid antagonist
0,038  0,035  Acetyl-CoA carboxylase inhibitor
0,041  0,039  Dipeptidyl peptidase IV inhibitor
0,049  0,047  Beta 1 adrenoreceptor antagonist
0,149  0,147  Antineoplastic (lymphoma)
0,067  0,065  Orexin receptor 1 antagonist
0,057  0,055  5 Hydroxytryptamine 3 agonist
0,117  0,116  Genotoxic
0,093  0,093  Topoisomerase II inhibitor
0,131  0,131  Embryotoxic

